                         SEQUENCE LISTING

<110>  PamGene B.V.
       Erasmus University Medical Center Rotterdam
 
<120>  METHOD FOR PREDICTING THE RESPONSE OF NON-SMALL-CELL LUNG 
       CARCINOMA PATIENTS TO A MEDICAMENT

<130>  PAM-071-PCT

<150>  EP17185467.2
<151>  2017-08-09

<160>  22    

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  artificial sequence

<220>
<223>  ART_004_EAIYAAPFAKKKXC

<400>  1

Glu Ala Ile Tyr Ala Ala Pro Phe Ala Lys Lys Lys 
1               5                   10          


<210>  2
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  ERBB4_1277_1289

<400>  2

Ile Val Ala Glu Asn Pro Glu Tyr Leu Ser Glu Phe Ser 
1               5                   10              


<210>  3
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  FGFR2_762_774

<400>  3

Thr Leu Thr Thr Asn Glu Glu Tyr Leu Asp Leu Ser Gln 
1               5                   10              


<210>  4
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  LAT_194_206

<400>  4

Met Glu Ser Ile Asp Asp Tyr Val Asn Val Pro Glu Ser 
1               5                   10              


<210>  5
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  ZAP70_485_497

<400>  5

Ala Leu Gly Ala Asp Asp Ser Tyr Tyr Thr Ala Arg Ser 
1               5                   10              


<210>  6
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  MK01_180_192

<400>  6

His Thr Gly Phe Leu Thr Glu Tyr Val Ala Thr Arg Trp 
1               5                   10              


<210>  7
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  FAK2_572_584

<400>  7

Arg Tyr Ile Glu Asp Glu Asp Tyr Tyr Lys Ala Ser Val 
1               5                   10              


<210>  8
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  PAXI_24_36

<400>  8

Phe Leu Ser Glu Glu Thr Pro Tyr Ser Tyr Pro Thr Gly 
1               5                   10              


<210>  9
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  TNNT1_2_14

<400>  9

Ser Asp Thr Glu Glu Gln Glu Tyr Glu Glu Glu Gln Pro 
1               5                   10              


<210>  10
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  ANXA1_14_26

<400>  10

Ile Glu Asn Glu Glu Gln Glu Tyr Val Gln Thr Val Lys 
1               5                   10              


<210>  11
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  DYR1A_212_224

<400>  11

Lys His Asp Thr Glu Met Lys Tyr Tyr Ile Val His Leu 
1               5                   10              


<210>  12
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  41_654_666

<400>  12

Leu Asp Gly Glu Asn Ile Tyr Ile Arg His Ser Asn Leu 
1               5                   10              


<210>  13
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  FGFR3_753_765

<400>  13

Thr Val Thr Ser Thr Asp Glu Tyr Leu Asp Leu Ser Ala 
1               5                   10              


<210>  14
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  LAT_249_261

<400>  14

Glu Glu Gly Ala Pro Asp Tyr Glu Asn Leu Gln Glu Leu 
1               5                   10              


<210>  15
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  CBL_693_705

<400>  15

Glu Gly Glu Glu Asp Thr Glu Tyr Met Thr Pro Ser Ser 
1               5                   10              


<210>  16
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  KSYK_518_530

<400>  16

Ala Leu Arg Ala Asp Glu Asn Tyr Tyr Lys Ala Gln Thr 
1               5                   10              


<210>  17
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  PGFRB_1014_1028

<400>  17

Pro Asn Glu Gly Asp Asn Asp Tyr Ile Ile Pro Leu Pro Asp Pro 
1               5                   10                  15  


<210>  18
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  EPOR_361_373

<400>  18

Ser Glu His Ala Gln Asp Thr Tyr Leu Val Leu Asp Lys 
1               5                   10              


<210>  19
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  JAK1_1015_1027

<400>  19

Ala Ile Glu Thr Asp Lys Glu Tyr Tyr Thr Val Lys Asp 
1               5                   10              


<210>  20
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  PRRX2_202_214

<400>  20

Trp Thr Ala Ser Ser Pro Tyr Ser Thr Val Pro Pro Tyr 
1               5                   10              


<210>  21
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  PDPK1_369_381

<400>  21

Asp Glu Asp Cys Tyr Gly Asn Tyr Asp Asn Leu Leu Ser 
1               5                   10              


<210>  22
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  EPHA1_774_786

<400>  22

Leu Asp Asp Phe Asp Gly Thr Tyr Glu Thr Gln Gly Gly 
1               5                   10              


